Cabaletta Bio
CABA
Cabaletta Bio (CABA) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.44
- EPS estimate
- −$0.47
- EPS surprise
- +6.72%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 10, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 10, 2025 | −$0.47 | −$0.44 | +6.72% | $0.00 | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.65 | −$0.73 | −12.39% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.65 | −$0.71 | −8.53% | $0.00 | SEC |
| Q4 2024 | Mar 31, 2025 | −$0.64 | −$0.65 | −1.71% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.60 | −$0.62 | −3.99% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.55 | −$0.56 | −2.25% | $0.00 | SEC |
| Q1 2024 | May 15, 2024 | −$0.48 | −$0.51 | −7.28% | $0.00 | SEC |
| Q4 2023 | Mar 21, 2024 | −$0.39 | −$0.46 | −17.14% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.40 | −$0.37 | +8.30% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.44 | −$0.37 | +15.91% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.48 | −$0.45 | +6.25% | $0.00 | SEC |
| Q4 2022 | Mar 16, 2023 | −$0.47 | −$0.52 | −11.04% | $0.00 | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.45 | −$0.39 | +13.33% | $0.00 | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.53 | −$0.45 | +14.56% | $0.00 | SEC |
| Q1 2022 | May 12, 2022 | −$0.59 | −$0.45 | +24.15% | $0.00 | SEC |
| Q4 2021 | Mar 17, 2022 | −$0.60 | −$0.49 | +18.14% | $0.00 | SEC |
| Q3 2021 | Nov 1, 2021 | −$0.50 | −$0.45 | +10.36% | $0.00 | SEC |
| Q2 2021 | Aug 5, 2021 | −$0.48 | −$0.45 | +7.02% | $0.00 | SEC |
| Q1 2021 | May 3, 2021 | −$0.49 | −$0.41 | +15.90% | $0.00 | SEC |
| Q4 2020 | Mar 16, 2021 | −$0.38 | −$0.40 | −4.17% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Cabaletta Bio (CABA) last report earnings?
Cabaletta Bio last reported on Nov 10, 2025, covering fiscal Q3 2025.
Did CABA beat earnings estimates?
Yes. Cabaletta Bio reported EPS of −$0.44 for Q3 2025 against a −$0.47 estimate — a 6.72% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
